D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.93% |
| 2 | Consumer Discretionary | 10.48% |
| 3 | Healthcare | 8.56% |
| 4 | Communication Services | 8.41% |
| 5 | Financials | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KC
2701
Kingsoft Cloud Holdings
KC
$3.03B
| $1.44M | ﹤0.01% |
36,524
-196,782
| -84% | -$10.4M |
|
2702
Rush Enterprises Class A
RUSHA
$6.13B
| $1.44M | ﹤0.01% |
43,194
+750
| +2% | +$22.4K |
|
2703
Cigna
CI
$79.6B
| $1.43M | ﹤0.01% |
5,933
-108,163
| -95% | -$24.1M |
|
|
AVYA
2704
CALL
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $1.43M | ﹤0.01% |
51,100
-60,000
| -54% | -$1.6M |
|
2705
Xencor
XNCR
$1.48B
| $1.43M | ﹤0.01% |
+33,209
| New | +$1.57M |
|
|
ZYNE
2706
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $1.43M | ﹤0.01% |
307,038
+268,880
| +705% | +$1.22M |
|
2707
MSCI
MSCI
$42.1B
| $1.43M | ﹤0.01% |
3,404
-970
| -22% | -$408K |
|
|
AXON
2708
CALL
Axon Enterprise
AXON
$44.1B
| $1.42M | ﹤0.01% |
10,000
-32,900
| -77% | -$5.13M |
|
2709
Upwork
UPWK
$1.21B
| $1.42M | ﹤0.01% |
31,812
-69,835
| -69% | -$3.22M |
|
|
PTOCU
2710
DELISTED
Pine TechnologYES Acquisition Corp. Unit
PTOCU
| $1.42M | ﹤0.01% |
+143,181
| New | +$1.42M |
|
2711
CALL
Nokia
NOK
$49.9B
| $1.42M | ﹤0.01% |
357,900
+328,600
| +1,122% | +$1.37M |
|
|
GIIXU
2712
DELISTED
Gores Holdings VIII, Inc. Unit
GIIXU
| $1.42M | ﹤0.01% |
+141,708
| New | +$1.44M |
|
2713
Banc of California
BANC
$3.27B
| $1.42M | ﹤0.01% |
78,248
+36,131
| +86% | +$671K |
|
2714
H.B. Fuller
FUL
$3.07B
| $1.41M | ﹤0.01% |
22,447
+7,489
| +50% | +$426K |
|
2715
CALL
NewMarket
NEU
$7.2B
| $1.41M | ﹤0.01% |
+3,700
| New | +$1.48M |
|
2716
Silicom
SILC
$219M
| $1.41M | ﹤0.01% |
31,158
+10,982
| +54% | +$513K |
|
|
NVTA
2717
DELISTED
Invitae Corporation
NVTA
| $1.4M | ﹤0.01% |
36,686
-776,400
| -95% | -$35.3M |
|
2718
Nexstar Media Group
NXST
$5.92B
| $1.4M | ﹤0.01% |
9,976
+2,993
| +43% | +$392K |
|
2719
ANI Pharmaceuticals
ANIP
$1.84B
| $1.4M | ﹤0.01% |
38,746
+12,286
| +46% | +$385K |
|
2720
CALL
Brinker International
EAT
$8.5B
| $1.4M | ﹤0.01% |
+19,700
| New | +$1.32M |
|
2721
PUT
International Flavors & Fragrances
IFF
$20.2B
| $1.4M | ﹤0.01% |
+10,000
| New | +$1.29M |
|
2722
CALL
Middleby
MIDD
$6.11B
| $1.39M | ﹤0.01% |
8,400
-30,000
| -78% | -$4.42M |
|
2723
CALL
PG&E
PCG
$39.2B
| $1.39M | ﹤0.01% |
118,800
-202,000
| -63% | -$2.35M |
|
2724
Dine Brands
DIN
$458M
| $1.39M | ﹤0.01% |
15,419
-98,418
| -86% | -$7.65M |
|
|
GTY
2725
Getty Realty Corp
GTY
$2.12B
| $1.38M | ﹤0.01% |
48,843
-18,427
| -27% | -$515K |
|
Similar funds
D.E. Shaw & Co's Q1 2021 Portfolio in Review
As of Q1 2021, D.E. Shaw & Co held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
D.E. Shaw & Co withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Baidu worth $627M.
- D.E. Shaw & Co's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- D.E. Shaw & Co added most to Tesla in Q1 2021, an estimated $862M increase.
- D.E. Shaw & Co's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- D.E. Shaw & Co fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- D.E. Shaw & Co's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- D.E. Shaw & Co opened 825 new positions and closed 730 in Q1 2021.
- D.E. Shaw & Co's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.